Nagai Yuzo, Kazama Sinsuke, Yamada Daisuke, Miyagawa Takuya, Murono Koji, Yasuda Koji, Nishikawa Takeshi, Tanaka Toshiaki, Kiyomatsu Tomomichi, Hata Keisuke, Kawai Kazushige, Masui Yuri, Nozawa Hiroaki, Yamaguchi Hironori, Ishihara Soichiro, Kadono Takafumi, Watanabe Toshiaki
Department of Surgical Oncology, The University of Tokyo Hospital, Tokyo, Japan.
Department of Dermatology, The University of Tokyo Hospital, Tokyo, Japan.
Ann Dermatol. 2016 Oct;28(5):624-628. doi: 10.5021/ad.2016.28.5.624. Epub 2016 Sep 30.
Treatment of perianal and vulvar extramammary Paget disease (EMPD), rare intraepithelial malignancies, is often challenging because of its potential to spread into the anal canal. However, there is still no consensus regarding the optimal resection margin within the anal canal. Between 2004 and 2014, six patients (three with perianal EMPD and three with vulvar EMPD) in which the spread of Paget cells into the anal canal was highly suspected were referred to our department. To evaluate the disease extent within the anal canal, preoperative mapping biopsy of the anal canal was performed in five out of six patients. Two patients were positive for Paget cells within the anal canal (one at the dentate line and the other at 0.5 cm above the dentate line), whereas in three patients, Paget cell were present only in the skin of the anal verge. Using 1 cm margin within the anal canal from the positive biopsy sites, we performed anal-preserving wide local excision (WLE), and negative resection margins within the anal canal were confirmed in all five patients. The remaining one patient with perianal EMPD did not undergo mapping biopsy of the anal canal because preoperative colonoscopy revealed that the Paget cells had spread into the lower rectum. Therefore, WLE with abdominoperineal resection was performed. During the median follow-up period of 37.3 months, no local recurrence was observed in all patients. Our small case series suggest the usefulness of mapping biopsy of the anal canal for the treatment of perianal and vulvar EMPD.
肛周和外阴部乳腺外佩吉特病(EMPD)是一种罕见的上皮内恶性肿瘤,由于其有可能扩散至肛管,其治疗往往具有挑战性。然而,关于肛管内最佳切除边缘仍未达成共识。2004年至2014年期间,6例患者(3例肛周EMPD和3例外阴EMPD)被转诊至我科,这些患者高度怀疑佩吉特细胞已扩散至肛管。为评估肛管内疾病范围,6例患者中有5例在术前进行了肛管定位活检。2例患者肛管内佩吉特细胞呈阳性(1例在齿状线处,另1例在齿状线以上0.5 cm处),而在3例患者中,佩吉特细胞仅存在于肛缘皮肤。我们从阳性活检部位起在肛管内采用1 cm切缘进行了保留肛门的广泛局部切除(WLE),所有5例患者肛管内切除边缘均为阴性。其余1例肛周EMPD患者未进行肛管定位活检,因为术前结肠镜检查显示佩吉特细胞已扩散至直肠下段。因此,进行了腹会阴联合切除的WLE。在37.3个月的中位随访期内,所有患者均未观察到局部复发。我们的小病例系列提示肛管定位活检对肛周和外阴EMPD治疗的有用性。